Abstract
Purpose: To investigate if the presence and severity of traction bronchiectasis/bronchiolectasis are associated with poorer survival in subjects with ILA. Method: The study included 3,594 subjects (378 subjects with ILA and 3,216 subjects without ILA) in AGES-Reykjavik Study. Chest CT scans of 378 subjects with ILA were evaluated for traction bronchiectasis/bronchiolectasis, defined as dilatation of bronchi/bronchioles within areas demonstrating ILA. Traction bronchiectasis/bronchiolectasis Index (TBI) was assigned as: TBI = 0, ILA without traction bronchiectasis/bronchiolectasis: TBI = 1, ILA with bronchiolectasis but without bronchiectasis or architectural distortion: TBI = 2, ILA with mild to moderate traction bronchiectasis: TBI = 3, ILA and severe traction bronchiectasis and/or honeycombing. Overall survival (OS) was compared among the subjects in different TBI groups and those without ILA. Results: The median OS was 12.93 years (95%CI; 12.67 – 13.43) in the subjects without ILA; 11.95 years (10.03 – not reached) in TBI-0 group; 8.52 years (7.57 – 9.30) in TBI-1 group; 7.63 years (6.09 – 9.10) in TBI-2 group; 5.40 years (1.85 – 5.98) in TBI-3 group. The multivariable Cox models demonstrated significantly shorter OS of TBI-1, TBI-2, and TBI-3 groups compared to subjects without ILA (P < 0.0001), whereas TBI-0 group had no significant OS difference compared to subjects without ILA, after adjusting for age, sex, and smoking status. Conclusions: The presence and severity of traction bronchiectasis/bronchiolectasis are associated with shorter survival. The traction bronchiectasis/bronchiolectasis is an important contributor to increased mortality among subjects with ILA.
Original language | English |
---|---|
Article number | 109073 |
Journal | European Journal of Radiology |
Volume | 129 |
DOIs | |
Publication status | Published - Aug 2020 |
Bibliographical note
Dr. Nishino is supported by NIH grant R01 CA203636. Dr. Putman is supported by NIH grant K08 HL140087. Dr. Gudmundsson is supported by project grant from the Icelandic Research Fund. Dr. Washko is supported by NIH grants R01 HL116473 and R01 HL122464. Dr. Christiani is supported by NIH (NCI) grant # U01CA209414. The Age, Gene/Environment Susceptibility-Reykjavik Study was supported by NIH contracts N01-AG-1-2100 and HHSN27120120022C, the NIA Intramural Research Program, Hjartavernd (the Icelandic Heart Association), and the Althingi (the Icelandic Parliament). Dr. Gudnason is supported by NIA grant: 27120120022C and project grant from the Icelandic Research Fund. Dr. Hunninghake is supported by NIH grants R01 HL111024, R01 HL130974, R01 135142, and project grant 141513-051 from the Icelandic Research Fund.Publisher Copyright:
© 2020 Elsevier B.V.
Other keywords
- Age Gene/Environment Susceptibility-Reykjavik Study
- Interstitial lung abnormality
- Pulmonary fibrosis
- Traction bronchiectasis
- Usual interstitial pneumonia